PKIB (Gene)

Synonyms:ENTREZ:5570, HGNC:9018, MIM:606914, NM_001270393, NM_001270394, NM_001270395, NM_032471, NM_181794, NM_181795, NP_001257322, NP_001257323, NP_001257324, NP_115860, NP_861459, NP_861460, PKIB, PRKACN2, XM_011535930, XM_011535931, XM_011535932, XM_011535933, XM_011535935, XM_011535936, XM_011535937, XP_011534232, XP_011534233, XP_011534234, XP_011534235, XP_011534237, XP_011534238, XP_011534239, cAMP-dependent protein kinase inhibitor beta
Omim:OMIM:606914
Id:8568e195-0f20-5250-99fa-8a430d04261a
Hgnc:HGNC:9018
Entrez:5570
Description:cAMP-dependent protein kinase inhibitor beta
This gene encodes a member of the cAMP-dependent protein kinase inhibitor family. The encoded protein may play a role in the protein kinase A (PKA) pathway by interacting with the catalytic subunit of PKA, and overexpression of this gene may play a role in prostate cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View PKIB's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with PKIB.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using PKIB.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for PKIB.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PKIB.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.